Life Sciences Opportunities in India & China: From Innovation to Commercialization
September 30, 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
June 8, 2026
Labor & Employment Law Perspectives
Illinois Provides Additional Protections to Workers on Publicly Funded Projects
In 2025, Illinois Governor J.B. Pritzker signed three new bills into law to amend the Illinois Prevailing Wage Act (the Act): HB 1189, SB 1344, and HB 2488. Now approaching almost one year with these amendments on the books, it is a good time for covered employers to assess their compliance.
June 8, 2026
Energy Current
Federal Court Vacates IRS Notice 2025-42: Five Percent Safe Harbor May be Restored for Wind and Solar Projects
On Saturday, June 6, 2026, the U.S. District Court for the District of Columbia vacated IRS Notice 2025-42 (the “Notice”), which…
June 8, 2026
Labor & Employment Law Perspectives
New Virginia Law Prohibits Noncompete Agreements With Health Care Professionals
Virginia lawmakers recently passed HB 627, effective July 1, 2026, banning noncompete agreements with “health care professionals.”